William E. Brady

6.3k total citations
116 papers, 4.4k citations indexed

About

William E. Brady is a scholar working on Reproductive Medicine, Surgery and Oncology. According to data from OpenAlex, William E. Brady has authored 116 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Reproductive Medicine, 33 papers in Surgery and 28 papers in Oncology. Recurrent topics in William E. Brady's work include Ovarian cancer diagnosis and treatment (37 papers), Endometrial and Cervical Cancer Treatments (14 papers) and Lipoproteins and Cardiovascular Health (12 papers). William E. Brady is often cited by papers focused on Ovarian cancer diagnosis and treatment (37 papers), Endometrial and Cervical Cancer Treatments (14 papers) and Lipoproteins and Cardiovascular Health (12 papers). William E. Brady collaborates with scholars based in United States, United Kingdom and Japan. William E. Brady's co-authors include Joanne Palmisano, Wendy P. Battisti, Ronald Klein, Julie A. Mares‐Perlman, Phyllis E. Bowen, Maria Stacewicz‐Sapuntzakis, David M. Gershenson, Heather A. Lankes, Mari Palta and Margo A. Denke and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

William E. Brady

114 papers receiving 4.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
William E. Brady United States 36 1.1k 978 958 672 646 116 4.4k
Nea Malila Finland 38 722 0.6× 679 0.7× 132 0.1× 2.1k 3.2× 232 0.4× 177 5.4k
Sandeep Mathur India 27 651 0.6× 735 0.8× 192 0.2× 926 1.4× 99 0.2× 270 3.0k
Vesa Kataja Finland 49 1.6k 1.4× 2.5k 2.5× 198 0.2× 4.0k 5.9× 188 0.3× 176 9.1k
Christine Bouchardy Switzerland 50 874 0.8× 1.3k 1.4× 320 0.3× 3.4k 5.0× 186 0.3× 168 7.2k
Lars Erik Rutqvist Sweden 53 1.4k 1.2× 1.2k 1.3× 143 0.1× 4.6k 6.9× 404 0.6× 153 9.4k
Claus Høgdall Denmark 42 1.0k 0.9× 1.6k 1.7× 3.0k 3.1× 1.4k 2.1× 90 0.1× 284 6.0k
Michele L. Coté United States 37 359 0.3× 1.4k 1.5× 650 0.7× 2.0k 3.0× 244 0.4× 161 5.1k
Yan Shi China 30 548 0.5× 1.1k 1.1× 134 0.1× 947 1.4× 312 0.5× 191 3.4k
Sharad Sharma India 32 860 0.8× 667 0.7× 60 0.1× 622 0.9× 155 0.2× 117 3.4k
Hideyuki Akaza Japan 50 3.1k 2.7× 2.7k 2.7× 242 0.3× 1.8k 2.6× 182 0.3× 517 9.7k

Countries citing papers authored by William E. Brady

Since Specialization
Citations

This map shows the geographic impact of William E. Brady's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William E. Brady with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William E. Brady more than expected).

Fields of papers citing papers by William E. Brady

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William E. Brady. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William E. Brady. The network helps show where William E. Brady may publish in the future.

Co-authorship network of co-authors of William E. Brady

This figure shows the co-authorship network connecting the top 25 collaborators of William E. Brady. A scholar is included among the top collaborators of William E. Brady based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William E. Brady. William E. Brady is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ochs‐Balcom, Heather M., et al.. (2020). Findings from Optometrists' Practices in Advising about Lifestyle Study. Optometry and Vision Science. 97(8). 598–605. 3 indexed citations
2.
Gershenson, David M., Austin Miller, William E. Brady, et al.. (2019). A randomized phase II/III study to assess the efficacy of trametinib in patients with recurrent or progressive low-grade serous ovarian or peritoneal cancer. Annals of Oncology. 30. v897–v898. 42 indexed citations
3.
Brown, Jubilee, R. Wendel Naumann, William E. Brady, et al.. (2018). Clinical trial methodology in rare gynecologic tumor research: Strategies for success. Gynecologic Oncology. 149(3). 605–611. 7 indexed citations
4.
Hutson, Alan D. & William E. Brady. (2017). Optimizing Tests about Survival Probabilities in the One-Arm Phase II Cancer Clinical Trial Setting. RePEc: Research Papers in Economics. 2(2). 30–37. 1 indexed citations
5.
6.
7.
Monk, Bradley J., Andrea Facciabene, William E. Brady, et al.. (2016). Integrative Development of a TLR8 Agonist for Ovarian Cancer Chemoimmunotherapy. Clinical Cancer Research. 23(8). 1955–1966. 29 indexed citations
8.
Zaino, Richard J., William E. Brady, Kimberly K. Leslie, et al.. (2014). Histologic Effects of Medroxyprogesterone Acetate on Endometrioid Endometrial Adenocarcinoma. International Journal of Gynecological Pathology. 33(6). 543–553. 31 indexed citations
9.
Fetterly, Gerald J., Yujie Zhao, Grace K. Dy, et al.. (2014). A phase I study to assess the safety, tolerability, and PK of dovitinib (D) in combination with gemcitabine (G) and capecitabine (C) in patients with advanced solid tumors.. Journal of Clinical Oncology. 32(15_suppl). 2603–2603. 1 indexed citations
10.
Ngamphaiboon, Nuttapong, Grace K. Dy, Wen Wee, et al.. (2014). A phase I study of the histone deacetylase (HDAC) inhibitor entinostat, in combination with sorafenib in patients with advanced solid tumors. Investigational New Drugs. 33(1). 225–232. 38 indexed citations
11.
Gold, Michael A., William E. Brady, Heather A. Lankes, et al.. (2012). A phase II study of a urokinase-derived peptide (A6) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube, or primary peritoneal carcinoma: A Gynecologic Oncology Group study. Gynecologic Oncology. 125(3). 635–639. 41 indexed citations
12.
13.
Abate, Nicola, Christie M. Ballantyne, Alberico L. Catapano, et al.. (2006). LDL-C-lowering efficacy of the ezetimibe/simvastatin single tablet compared with atorvastatin or roslivastatin in elderly patients with hype rcholesterolemia. Journal of the American Geriatrics Society. 54. 163–163. 10 indexed citations
14.
Guru, Khurshid A., et al.. (2006). Impact of Robotics and Laparoscopy on Surgical Skills: A Comparative Study. Journal of the American College of Surgeons. 204(1). 96–101. 40 indexed citations
15.
Reims, Henrik M., Suzanne Oparil, Sverre E. Kjeldsen, et al.. (2004). Losartan benefits over atenolol in non‐smoking hypertensive patients with left ventricular hypertrophy: The LIFE study. Blood Pressure. 13(6). 376–384. 14 indexed citations
16.
Ballantyne, Christie M., Michael A. Blazing, Thomas King, William E. Brady, & Joanne Palmisano. (2004). M.456 Efficacy of coadministered ezetimibe + simvastatin versus atorvastatin alone in adults with hypercholesterolemia. Atherosclerosis Supplements. 5(1). 105–105. 2 indexed citations
17.
Rolfs, Robert T., M R Joesoef, Edward F. Hendershot, et al.. (1997). A Randomized Trial of Enhanced Therapy for Early Syphilis in Patients with and without Human Immunodeficiency Virus Infection. New England Journal of Medicine. 337(5). 307–314. 372 indexed citations
18.
Brady, William E., Julie A. Mares‐Perlman, Phyllis E. Bowen, & Maria Stacewicz‐Sapuntzakis. (1996). Human Serum Carotenoid Concentrations Are Related to Physiologic and Lifestyle Factors. Journal of Nutrition. 126(1). 129–137. 192 indexed citations
19.
Brady, William E., Linda Nebeling, Gladys Block, et al.. (1996). Influence of Using Different Sources of Carotenoid Data in Epidemiologic Studies. Journal of the American Dietetic Association. 96(12). 1271–1275. 48 indexed citations
20.
Mares‐Perlman, Julie A., et al.. (1995). Serum carotenoids and tocopherols and severity of nuclear and cortical opacities.. PubMed. 36(2). 276–88. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nea Malila Breakdown of academic impact, for papers by Sandeep Mathur Breakdown of academic impact, for papers by Vesa Kataja Breakdown of academic impact, for papers by Christine Bouchardy Breakdown of academic impact, for papers by Lars Erik Rutqvist Breakdown of academic impact, for papers by Claus Høgdall Breakdown of academic impact, for papers by Michele L. Coté Breakdown of academic impact, for papers by Yan Shi Breakdown of academic impact, for papers by Sharad Sharma Breakdown of academic impact, for papers by Hideyuki Akaza
Rankless by CCL
2026